Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
NEW YORK, July 30, 2026--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causesβ¦





